Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study (Q37371731)

From Wikidata
Jump to navigation Jump to search
scientific article published on 07 September 2014
edit
Language Label Description Also known as
English
Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study
scientific article published on 07 September 2014

    Statements

    Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study (English)
    0 references
    0 references
    7 September 2014

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit